Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

NCT00591149 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Study was stopped due to termination of funding

Conditions

Head and Neck Cancer
Carcinoma, Squamous

Interventions

DRUG: Oxaliplatin
DRUG: Docetaxel
DRUG: Cetuximab

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]